'Femtech' funding soars to $1.9B in '21

Investors are seeing a growth opportunity in femtech as venture capital funding tripled to $1.9 billion in 2021, CNBC reported March 21.

Femtech, technology and software addressing women's biological needs, has seen venture capital funding triple from $600 million in 2015 to $1.9 billion in 2021 as early stage investors have an increased interest in tech companies focused on women's health conditions. Here are key points highlighting market growth:

  • Firms focused on gynecology, fertility and maternity have garnered the largest funding.

  • Femtech funding is being driven by the growth in large employers adopting services focused on maternal and family health.

  • The vast majority of femtech firms are led by women. 

Despite the increase in venture fund investments, analysts say the overall investment in women's health still remains underfunded.

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars